Task: Answer the multiple-choice question.
Question: Which compound exhibits a -20.041% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any additional words.
Options:
[a] O=C(O)CC(SCC(=O)Nc1ccc(S(=O)(=O)N2CCCC2)cc1)C(=O)O
[b] CN(CC(=O)NCC(c1ccco1)N1CCCCC1)S(=O)(=O)c1ccc(Cl)cc1
[c] CCc1cc2ccc(C)cc2nc1SCC(=O)Nc1cc(OC)c(OC)cc1C(=O)O
[d] CCN1C(=O)C2(Nc3ccccc3-c3nc4ccccc4n32)c2cc(OC)ccc21
[e] CC1CCN(C(=O)CNS(=O)(=O)c2ccc(Br)s2)CC1
Answer: e. CC1CCN(C(=O)CNS(=O)(=O)c2ccc(Br)s2)CC1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CC1CCN(C(=O)CNS(=O)(=O)c2ccc(Br)s2)CC1
CC1CCN(C(=O)CNS(=O)(=O)c2ccc(Br)s2)CC1
5-bromo-N-[2-(4-methylpiperidin-1-yl)-2-oxoethyl]thiophene-2-sulfonamide